Article
As COMPASS Pathways continues its attempts to build a psychedelic monopoly, Usona Institute keeps publishing open research
Since COMPASS Pathways filed for a controversial psilocybin patent in 2018, Usona Institute has consistently placed its research findings in the public domain.